Effects of medroxyprogesterone acetate on liver glucose metabolism in rats with streptozotocin induced diabetes mellitus.
Stengård
J H
JH
National Public Health Institute, Helsinki, Finland.
Saarni
H U
HU
Rautio
A
A
Knip
M
M
Stenbäck
F
F
Sotaniemi
E A
EA
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D005952:Glucose-6-Phosphatase / Q000032:analysis; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D006003:Glycogen / Q000032:analysis; D007328:Insulin / Q000097:blood; D008099:Liver / Q000737:chemistry / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D010734:Phosphogluconate Dehydrogenase / Q000032:analysis; D051381:Rats; D011919:Rats, Inbred Strains; D013311:Streptozocin
D007328:Insulin; D013311:Streptozocin; D006003:Glycogen; D017258:Medroxyprogesterone Acetate; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005952:Glucose-6-Phosphatase; D008525:Medroxyprogesterone; D005947:Glucose